A phase II study assessing CYNK-001 for acute myeloid leukemia
Latest Information Update: 13 Jan 2021
At a glance
- Drugs Taniraleucel (Primary)
- Indications Acute myeloid leukaemia
- Focus Therapeutic Use
- Sponsors Celularity
- 13 Jan 2021 New trial record
- 08 Jan 2021 According to a Celularity media release, this study is expected to commence in 2021.